Cargando…
Calling for benefit–risk evaluations of COVID-19 control measures
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906630/ https://www.ncbi.nlm.nih.gov/pubmed/33549169 http://dx.doi.org/10.1016/S0140-6736(21)00193-8 |
_version_ | 1783655329940111360 |
---|---|
author | Kampf, Günter Kulldorff, Martin |
author_facet | Kampf, Günter Kulldorff, Martin |
author_sort | Kampf, Günter |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7906630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79066302021-02-26 Calling for benefit–risk evaluations of COVID-19 control measures Kampf, Günter Kulldorff, Martin Lancet Correspondence Elsevier Ltd. 2021 2021-02-04 /pmc/articles/PMC7906630/ /pubmed/33549169 http://dx.doi.org/10.1016/S0140-6736(21)00193-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Kampf, Günter Kulldorff, Martin Calling for benefit–risk evaluations of COVID-19 control measures |
title | Calling for benefit–risk evaluations of COVID-19 control measures |
title_full | Calling for benefit–risk evaluations of COVID-19 control measures |
title_fullStr | Calling for benefit–risk evaluations of COVID-19 control measures |
title_full_unstemmed | Calling for benefit–risk evaluations of COVID-19 control measures |
title_short | Calling for benefit–risk evaluations of COVID-19 control measures |
title_sort | calling for benefit–risk evaluations of covid-19 control measures |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906630/ https://www.ncbi.nlm.nih.gov/pubmed/33549169 http://dx.doi.org/10.1016/S0140-6736(21)00193-8 |
work_keys_str_mv | AT kampfgunter callingforbenefitriskevaluationsofcovid19controlmeasures AT kulldorffmartin callingforbenefitriskevaluationsofcovid19controlmeasures |